Esto se debe a que la dosis de Ozempic es adecuada para el control de la diabetes, mientras que la dosis de Wegovy es ms alta, ya que tiene un mayor efecto en la prdida de peso
In a retrospective cohort analysis, Henney and colleagues evaluated adults with OSA and type 2 diabetes from TriNetX to determine how the risk for incident major adverse cardiovascular events (MACEs) acute coronary syndrome, heart failure, cerebrovascular accident, and sudden cardiac death differs with the GIP/GLP-1 dual agonist tirzepatide (Mounjaro/Zepbound, Eli Lilly) vs
Material verification focuses on physicochemical characterization and quality parameters relevant to peptide identity and receptor interaction studies
Ototoxic Medications (Medication Effects)
doi:10.1001/jama.2024.9217 JAMA _028463-68
1.3 GLP-1 RAs: clinical benefits and current applications Robust RCTs have demonstrated striking weight loss with GLP-1 RAs in adolescents (Table 2)